It’s a lifesaving treatment for people with high blood pressure and can help prevent blood clots and the progression of many types of blood cancers.
But, the drug is currently available only in Canada, Mexico, the United States and the European Union.
Now, researchers at the University of California, San Francisco have created a blood pressure control device that they say can work with the most common blood pressure medications.
The device is a portable blood pressure monitor that can detect the rate at which blood pressure drops, as well as the rate of blood clotting.
“We’ve been working on this for quite some time,” said Dr. Thomas Zwiebel, a senior lecturer in bioengineering at UC San Francisco.
“We have developed a system that can work on most drugs, and it is effective and has a very low side-effect profile.”
Zwiebell and his colleagues designed the device with the help of the FDA.
“The device, called the blood pressure monitoring platform, works like a traditional blood pressure cuff, but it’s portable,” Zwieslber said.
“You can wear it around the body, and you can even have it attached to your belt.
The device is not attached to a collar, which is more cumbersome.”
The device has been shown to reduce blood pressure in about 25% of people with hypertension, which causes high blood pressures.
In a clinical trial in patients with high-risk hypertension, Zwiestlber and his team demonstrated that the device reduced the risk of death and other complications of high blood blood pressure.
The team is now trying to improve on the device by designing a device that can also detect when the blood vessels have ruptured.
“There’s some evidence that that’s a good test for when you have a blood clot,” Zweier said.
The drug is available in Mexico, Canada, the U.S. and the EU, but currently, it only works in the most popular countries in the world.
The research team hopes to eventually develop a device in the U.
“We’re hoping that eventually we can have the devices work with any drug in the marketplace,” Zwaier said, adding that the devices could be manufactured in a lab, which could help ensure that the drug’s safety is not compromised.
Zwiesla said he is hopeful that the researchers can produce a device with more advanced features in the future.
“If we can get it to work with a drug that works well, then we can go ahead and make the device for other people,” he said.